Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: the FLAGS trial. - Wikidata - wikimedia - TriplyDB

Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: the FLAGS trial.

Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: the FLAGS trial.

http://www.wikidata.org/entity/Q34616772

about

Treatment of gastric cancer The European Medicines Agency review of Tegafur/Gimeracil/Oteracil (Teysuno™) for the treatment of advanced gastric cancer when given in combination with cisplatin: summary of the Scientific Assessment of the Committee for medicinal products for hum Current and emerging therapies in unresectable and recurrent gastric cancer Perioperative and Palliative Chemotherapy for Esophageal Cancer Advanced gastric cancer: Current treatment landscape and future perspectives Chemotherapy in Elderly Patients with Gastric Cancer Personalized medicine in gastric cancer: Where are we and where are we going?Emerging role of S-1 in gastric cancer Gastric cancer: The times they are a-changin'Clinical utility of ramucirumab in advanced gastric cancer Multimodal treatment of gastric cancer in the west: Where are we going?Efficacy of S-1 vs capecitabine for the treatment of gastric cancer: a meta-analysis S-1-based vs non-S-1-based chemotherapy in advanced gastric cancer: a meta-analysis The efficacy and safety of S-1-based regimens in the first-line treatment of advanced gastric cancer: a systematic review and meta-analysis.Epstein-Barr virus-positive gastric cancer: a distinct molecular subtype of the disease?Positioning of second-line treatment for advanced gastric and gastroesophageal junction adenocarcinoma Adjuvant and/or neoadjuvant therapy for gastric cancer? A perspective review Molecular classification of gastric cancer: a new paradigm.Phase II trial of S-1 plus leucovorin in patients with advanced gastric cancer and clinical prediction by S-1 pharmacogenetic pathway A phase I study of S-1 and irinotecan combination therapy in previously treated advanced non-small cell lung cancer patients.A phase II multi-center study of triple therapy with paclitaxel, S-1 and cisplatin in patients with advanced gastric cancer.Comparative analysis of the efficacy and safety of chemotherapy with oxaliplatin plus fluorouracil/leucovorin between elderly patients over 65 years and younger patients with advanced gastric cancer.Irinotecan plus mitomycin C as second-line chemotherapy for advanced gastric cancer resistant to fluoropyrimidine and Cisplatin: a retrospective study.Phase II study of palliative S-1 in combination with cisplatin as second-line chemotherapy for gemcitabine-refractory pancreatic cancer patients.Phase I/II trial of a biweekly combination of S-1 plus docetaxel in patients with previously treated non-small cell lung cancer (KRSG-0601).A phase II study of cisplatin /S-1 in patients with carcinomas of unknown primary site.Mitomycin C and capecitabine in pretreated patients with metastatic gastric cancer: a multicenter phase II study.S-1-based versus 5-FU-based chemotherapy as first-line treatment in advanced gastric cancer: a meta-analysis of randomized controlled trials.Effectiveness and safety profile of S-1-based chemotherapy compared with capecitabine-based chemotherapy for advanced gastric and colorectal cancer: A meta-analysis.Survival benefit from S-1 as compared to Fluorouracil in Asian patients with advanced gastrointestinal cancer: a meta-analysis.Vorinostat in combination with capecitabine plus cisplatin as a first-line chemotherapy for patients with metastatic or unresectable gastric cancer: phase II study and biomarker analysis.Can S-1 replace fluorouracil for advanced gastric cancer? A PRISMA-compliant systematic review and meta-analysis Oral fluoropyrimidine versus intravenous 5-fluorouracil for the treatment of advanced gastric and colorectal cancer: meta-analysis.Clinical evaluation of cetuximab combined with an S-1 and oxaliplatin regimen for Chinese patients with advanced gastric cancer.Prognostic impact of fibroblast growth factor receptor 2 gene amplification in patients receiving fluoropyrimidine and platinum chemotherapy for metastatic and locally advanced unresectable gastric cancers.Efficacy and safety comparison of chemotherapies for advanced gastric cancer: A network meta-analysis.Towards personalized perioperative treatment for advanced gastric cancer.Targeted therapies for gastric cancer: current status.Stratified phase II trial to establish the usefulness of the collagen gel droplet embedded culture-drug sensitivity test (CD-DST) for advanced gastric cancer.Capecitabine in gastric cancer.

P2860

Q24602875-2C9882E5-AA92-47CC-AFCD-67E05DB451AF Q24633301-D3D0E50C-172A-4588-BFAE-F4F2B1B38BD1 Q26745453-64521BA0-33DB-40C5-BA9E-71AEF63CDF2D Q26753865-269048C6-0946-45D2-A6DA-A3448695FC87 Q26764934-3F1CF7B8-915F-4988-A59C-2CAC607C59D7 Q26771424-4E028E83-F6B7-4F5E-8FC9-111A97883188 Q26774521-F3153C0C-A7E1-4325-8050-15F2A6F62E24 Q26774720-64159D4D-37CE-473C-91FF-0DEBD7B4A979 Q26776195-E1897681-F239-444D-AE7E-43A6C6D407C3 Q26785665-6298180E-F067-4D14-A900-C8D95FDEF137 Q26799748-3E8D8138-636E-4BA4-B3DF-2FEDE7F82893 Q26865057-47B41DD1-44ED-4E32-974D-DE4B6AF79792 Q27002415-9618B0AD-2EB5-4D94-8820-65A63ECBD742 Q27318805-A02D9A2E-54FB-40B4-84DD-02A65126F40D Q28075698-48717985-DD01-4F11-B630-E7FE27BEFF96 Q28079750-BE400D68-3E97-40C9-8F10-AE87711408A2 Q28088619-3A2FE812-4C68-4893-80E1-C11F006AA869 Q30500375-F4158A81-BF8F-4512-AC7A-AD0902A2907A Q30834530-CE12675F-CC98-4BEE-9382-EBB5491CC118 Q33393268-FB54EE11-96B0-46FD-B007-2F5CF1D0E6B0 Q33395721-8FA95153-6657-44B6-B518-9D891ABD0447 Q33399154-006FC380-3306-451A-8A3B-DEEDF1D6E5B6 Q33400558-A213F5FB-9CE3-47F3-A851-9FA331F1FC6B Q33402271-C3FE0342-E9B6-4F79-8871-7F07E7FFF044 Q33403640-28A989AA-D217-4CF2-9320-D4B5B64FDCA0 Q33409979-AB350338-A4DC-4F30-AB1D-4C084F51A132 Q33413448-5D684CAD-F0CC-4494-9763-CAFD78AE5709 Q33415440-17795664-8B9A-4DA5-BF1B-FE5F84DA2A61 Q33415971-87BF9383-04D5-4F73-940D-A745AF1402F8 Q33416158-26FED2E9-804A-4D3D-A986-B0BC5747D478 Q33432199-BCBD3A52-B1B8-4820-8836-57B3B86738AB Q33433129-EEE8CACB-81AD-4E5D-A6FE-AEF5E6407008 Q33442681-24F57919-DCF0-43ED-840F-E1507759DAAD Q33609291-5934B095-DBB2-43F0-A98B-441F65760D5E Q33779701-A6619ABB-C116-46D9-B130-953B554B012C Q33889328-2F44D193-32AE-48B3-8A6E-CA1692068915 Q34137285-58DEC916-0A62-4520-A132-789FBAD6F321 Q34205672-6A71EA82-AB98-4BAE-94CC-7E05CD586473 Q34216314-7AD63CE5-3607-4CE3-BD44-A1BC2BABBDBC Q34236005-7C761181-A633-44CD-AAB3-E447CE7FB7A8

P2860

Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: the FLAGS trial.

http://www.wikidata.org/entity/Q34616772

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Multicenter phase III comparis ...... cinoma study: the FLAGS trial.

@ast

Multicenter phase III comparis ...... cinoma study: the FLAGS trial.

@en

Multicenter phase III comparis ...... cinoma study: the FLAGS trial.

@nl

type

label

Multicenter phase III comparis ...... cinoma study: the FLAGS trial.

@ast

Multicenter phase III comparis ...... cinoma study: the FLAGS trial.

@en

Multicenter phase III comparis ...... cinoma study: the FLAGS trial.

@nl

prefLabel

Multicenter phase III comparis ...... cinoma study: the FLAGS trial.

@ast

Multicenter phase III comparis ...... cinoma study: the FLAGS trial.

@en

Multicenter phase III comparis ...... cinoma study: the FLAGS trial.

@nl

P1433

Q34616772-8A2CC70F-2744-4EE5-809B-8345DE987F6B

P1476

Q34616772-43592F35-936A-40DA-9287-094BF60E6C78

P2093

Q34616772-0D1E168E-20DC-49A1-9BF9-BF953BEC3270

Q34616772-1B75C60B-8F9E-42B6-AFDD-0E27075A4B7E

Q34616772-444E930F-5394-40CA-9235-FB86BCDCC7EC

Q34616772-4B065CB2-BA28-40D0-A222-8859CF2F7852

Q34616772-5C28D826-BBAD-49C1-8BEB-E8AC04BB9305

Q34616772-5D314B00-52BE-4DF8-ABC8-5FC5A6402EFB

Q34616772-7E9AFC5C-827F-42E7-8645-3640F0999211

Q34616772-86D43715-EE85-4B64-8A07-A9032B5C694F

Q34616772-983D6D72-5CBE-4C4A-B860-E3FE33E76B2B

Q34616772-D7DDA6D9-7900-41AC-8971-3925D5B0541D

P304

Q34616772-D4253A90-7C1C-45C6-BE6C-1BFF90791F2D

P31

Q34616772-9DB0D2C8-1CBD-4FB8-97A5-415686EC67ED

P356

Q34616772-1AB06EA5-DE43-48C2-B502-D04BE46CB6E8

P407

Q34616772-C3D15125-2ABB-44A2-BE2C-DC7BDB0A56FD

P433

Q34616772-CA40F48C-3A19-4C10-BB46-8DA4F6BB331C

P478

Q34616772-42BF5C2B-08C7-4566-949E-7A534A5F19B0

P577

Q34616772-32DEFB2E-C9D6-44B6-8378-CBCEA7E3F20E

P698

Q34616772-3333F08F-E806-4829-A1DB-9F3F22157661

P921

Q34616772-2A2E0CC4-0A77-42B0-A70E-894C2EF06CFD

Q34616772-4707AFC9-8460-4FC5-87C4-FE2DEEF543CF

Q34616772-FA974162-A645-49D6-A6B5-FCBF87A87F03

P356

JCO.2009.25.4706

P1433

Journal of Clinical Oncology

P1476

Multicenter phase III comparis ...... cinoma study: the FLAGS trial.

@en

P2093

August Garin

http://www.w3.org/2001/XMLSchema#string

Gyorgy Bodoky

http://www.w3.org/2001/XMLSchema#string

Ihor Vynnychenko

http://www.w3.org/2001/XMLSchema#string

Istvan Lang

http://www.w3.org/2001/XMLSchema#string

Jaffer A Ajani

http://www.w3.org/2001/XMLSchema#string

Mikhail Lichinitser

http://www.w3.org/2001/XMLSchema#string

Silvia Falcon

http://www.w3.org/2001/XMLSchema#string

Vera Gorbunova

http://www.w3.org/2001/XMLSchema#string

Vladimir Moiseyenko

http://www.w3.org/2001/XMLSchema#string

Wuilbert Rodriguez

http://www.w3.org/2001/XMLSchema#string

P304

1547-1553

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2009.25.4706

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20159816

http://www.w3.org/2001/XMLSchema#string

P921

phase III clinical trial

multicenter trial